Physician profile
Yu Htwe
NPI 1780094136
$12,624.89
in general payments reported to CMS, 2019-2025
15 companies · $7,997 in 2025
The $7,997 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.29 · 2021: $59.37 · 2022: $53.14 · 2023: $3,463 · 2024: $1,028 · 2025: $7,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,053 · Education: $4,000 · Food and Beverage: $2,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,052.73 |
| Education | $4,000.00 |
| Food and Beverage | $2,435.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,464.80 | 2021-2025 | |
| Pulmonx Corporation | $2,957.58 | 2023-2025 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Medical Device Business Services, INC. | $1,776.14 | 2023 | Na, Monarch |
| Steris Corporation | $807.13 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $232.84 | 2024-2025 | Tezspire, Fasenra |
| Mirati Therapeutics, INC. | $120.00 | 2023 | Krazati |
| Olympus America INC. | $69.40 | 2025 | |
| Viatris Specialty LLC | $57.97 | 2025 | Yupelri |
| Ge Healthcare | $27.00 | 2025 | |
| Sanofi Pasteur INC. | $24.29 | 2019 | |
| Medtronic, INC. | $22.18 | 2025 | Illumisite |
| Grifols USA, LLC | $17.90 | 2025 | Prolastin-C Liquid |
| Avadel Cns Pharmaceuticals, LLC | $16.65 | 2025 | Lumryz |
| Mallinckrodt Hospital Products INC. | $16.64 | 2025 | Acthar |
| Glaxosmithkline, LLC. | $14.37 | 2024 | Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yu Htwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.